Pfizer Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Pfizer Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue62.5863.6359.55100.3381.2941.6541.1740.83
Cost of Revenue15.1421.7824.9534.3430.828.488.258.99
Gross Profit47.4441.8534.6065.9950.4733.1732.9231.84
Operating Expenses
Research & Development10.4410.7410.8712.3813.839.398.397.76
Selling, General & Administrative12.9614.7314.7713.6812.7011.6012.7512.61
Operating Expenses28.2825.3630.3828.7130.2320.9921.1425.11
Operating Income19.1616.484.2231.3920.2412.1811.786.73
Other Income/Expense
Interest Income0.870.551.620.570.040.350.000.33
Interest Expense-2.673.092.21-1.241.29-1.450.001.32
Other Income/Expense0.34-8.46-2.58-1.565.331.21-4.77-2.15
Income
Income Before Tax7.528.021.0634.7324.317.0411.493.59
Income Tax Expense-0.27-0.03-1.123.331.850.370.62-0.27
Net Income7.778.022.1231.3721.989.1616.2711.15
Net Income - Continuous Operations7.778.022.1731.4022.460.000.000.00
Net Income - Discontinued Operations0.000.01-0.020.01-0.430.000.000.00
EBITDA25.6918.139.5641.0330.7913.2618.8511.06
EBIT19.1611.113.2735.9725.608.4913.064.91
Depreciation & Amortization6.537.014.735.063.704.686.014.74
Earnings Per Share
Basic EPS1.001.00-6.004.002.003.002.00
Diluted EPS1.001.00-5.004.002.003.002.00
Basic Shares Outstanding5.685.665.645.615.605.565.575.87
Diluted Shares Outstanding5.715.705.715.735.715.635.685.98